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Abstract
Background: Primary squamous cell carcinoma of the ampulla of Vater is a very rare type of tumor, and the
prognosis is not well known mainly due to a limited number of cases reported. Here, we aimed to report a case
with primary squamous cell carcinoma of the ampulla of Vater.
Case presentation: A 54-year-old woman presented with weight loss, jaundice, and pain in the epigastric and
right upper quadrant of the abdomen. With extensive radiological imaging, the patient was diagnosed with
periampullary tumor and Whipple’s procedure was performed. The immunohistochemical analyses supported the
diagnosis of primary squamous cell carcinoma. The postoperative course was uneventful. The patient was
discharged, and adjuvant chemotherapy was recommended.
Conclusion: Primary squamous cell carcinoma of the ampulla of Vater is a very rare histological type with an
unclear pathogenesis. A better understanding of pathogenesis might be helpful in optimizing the treatment for this
specific rare type of tumor.
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Background
Periampullary cancers include a group of malignant
tumors arising in the pancreas, the distal common
bile duct, the ampulla of Vater, and the duodenum.
Pathologic examination of resected pancreaticoduode-
nectomy specimens reveal that 40–60 % are adenocar-
cinomas of the head of the pancreas, 10–20 % are
adenocarcinomas of the ampulla of Vater, 10 % are
distal bile duct adenocarcinomas, and 5–10 % are
duodenal adenocarcinomas [1].
The most common histopathology of tumors in the
ampulla of Vater is adenocarcinomas followed by ade-
nosquamous [2–4] and squamous cell carcinomas. To
our knowledge, there are only four case reports with
primary squamous cell carcinoma [5–8] and one case
report with co-existent primary squamous cell carcin-
oma and adenocarcinoma in the ampulla of Vater [9].
Here, we aimed to report a case with primary squa-
mous cell carcinoma of the ampulla of Vater.
Case presentation
A 54-year-old woman applied to an out medical cen-
ter with the complaints of weight loss, jaundice, and
pain in the epigastric and right upper quadrant of the
abdomen. Computer tomography (CT) scan revealed
a mass with a size of 13 mm in the ampullary region
consistent with periampullary tumor (Fig. 1).
The patient underwent an endoscopic retrograde
cholangiopancreatography (ERCP) procedure which
revealed significant dilatation in the middle and distal
segments of the common bile duct together with an
abrupt ending in the distal segment of the common
bile duct. A plastic stent was inserted to the com-
mon bile duct via ERCP, and multiple biopsies were
taken from the periampullary region. The histo-
pathological result was squamous cell carcinoma. The
patient was referred to our hospital for further
investigations.
The physical examination of the patient was
unremarkable. Laboratory tests revealed elevated ALP
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(200 U/l; normal range, 30–120 U/l) and GGT
(181 U/l; normal range, 0–38 U/l) levels. Billirubin
level was within the normal limits. The serum level
of the tumor markers of CEA and CA-125 were 2.41
and 14.23 ng/ml (normal range, 0–35 U/ml), res-
pectively. CA-19-9 was 47.47 U/ml (normal range,
0–27 U/ml).
Magnetic resonance imaging (MRI) and magnetic
resonance cholangiopancreatography (MRCP) exami-
nations demonstrated a T1 hypointense lesion with a
size of 43 × 43 mm in the periampullary region
occluding the distal segment of the common bile duct
(Figs. 2, 3, and 4).
Because of the low incidence of squamous cell
carcinoma in the periampullary region, primary ma-
lignancies of other organs were also explored. Posi-
tron emission tomography (PET CT) revealed FDG
Fig. 1 Arterial phase CT scan of a 54-year-old woman shows a
high-density stent in the bile duct and a hypodense tumoral lesion
in the periampullary region
Fig. 2 Contrast-enhanced T1-weighted MRI shows a hypointense
lesion in the periampullary region near normal hyperintense
pancreatic tissue
Fig. 3 T2-weighted MRI shows the hypointense tumoral lesion in
the periampullary region which has a crescent-like shape
Fig. 4 MIP image of the MRCP shows significant dilatation of the
intrahepatic and proximal extrahepatic bile ducts with maximum
dimension of 14 mm. Note that the tumoral lesion extends to the
distal part of extrahepatic bile duct
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(fluorodeoxy-glucose) uptake only in the periampul-
lary region of the pancreas (Fig. 5).
The patient underwent an explorative laparotomy.
Upon confirmation of neither lymphovascular inva-
sion nor solid organ metastases, we decided to
proceed with Whipple’s procedure. The postoperative
course of the patient was uneventful. The patient
was discharged, and adjuvant chemotherapy was
recommended.
The histopathological examination demonstrated a
moderately differentiated squamous cell carcinoma
of periampullary tumor with a size of 3.7 × 3.1 ×
2.1 cm, invading the duodenum and pancreas
(Fig. 6).
Multiple serial sections of the tumor specimen
failed to detect any adenomatous component. Al-
though there were no signs of lymphovascular
invasion, perineural invasion was present in the
samples. Upon these findings, the tumor was staged
as pT3N0M0.
Immunohistochemical analysis showed that tumor
cells were positive for p63 and high molecular-weight
cytokeratin (HMWCK). To exclude other possible
origins of primary squamous cell carcinoma, additio-
nal immunohistochemical staining analyses were per-
formed. Tumor cells were negative for synaptophysin
and chromogranin, ruling out neuroendocrine origin.
Similarly, thyroid transcription factor-1 (TTF1) and
CK19 were negative, excluding primary squamous cell
cancer of the lung and cholangiocarcinoma. Photo-
micrographs of the resected specimen are shown in
Figs. 7, 8, 9, and 10.
Discussion
Distal common bile duct, ampullary, and duodenal
cancers are less common than pancreatic cancer [1].
The most common histopathological type of tumor in
the ampulla of Vater is adenocarcinoma. Other pri-
mary tumors that have been reported in the ampulla
of Vater are squamous cell carcinoma, neuroendo-
crine carcinoma [10, 11], and signet cell carcinoma
[12, 13]. There are only four case reports with
primary squamous cell carcinoma [5–8] and one case
report with co-existent primary squamous cell carcin-
oma and adenocarcinoma in the ampulla of Vater [9].
Because of the rarity of primary squamous cell
carcinoma in the ampulla of Vater, other primary
squamous cell malignancies must be excluded in all
the patients. Buyukcelık et al. reported a case of
Fig. 5 In axial PET image, FDG 18 (fluorodeoxy-glucose) uptake
is seen in the periampullary region
Fig. 6 a Tumor location in the common bile duct. b Tumor invasion to the duodenum (on the left) and to the pancreas (on the right)
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squamous cell carcinoma of the larynx [14], and
Sreenarasimhaiah and Hoang reported a case of
esophageal squamous cell carcinoma metastasized to
the ampulla of Vater [15]. Therefore, in the present
case, extensive imaging studies with CT, MRI, and
PET CT were performed to rule out other possible
origins.
There are also few case reports of neuroendocrine
carcinoma of the ampulla of Vater with squamous cell
components [10, 11]. Sugawara et al. reported a case
of small cell neuroendocrine carcinoma of the
ampulla of Vater with foci of squamous differenti-
ation. In their case, immunohistochemical analyses in-
cluding synaptophysin, chromogranin, neuron-specific
enolase (NSE), and Leu-7 were performed to identify
neuroendocrine cells, and squamous cell carcinoma
components were weakly positive for NSE [10]. In
our case, after revealing squamous cell carcinoma by
HMWCK and p63, additional staining analyses with
synaptophysin and chromogranin were performed to
exclude a neuroendocrine component.
The ampulla of Vater is normally devoid of squamous
cells. Although the malignant transformation of ectopic
squamous epithelium, the differentiation of the duodenal
pluripotent stem cells [16], and squamous metaplasia
secondary to chronic inflammation [17] are all among
the proposed mechanisms, the exact pathogenesis of pri-
mary squamous cell carcinoma in the ampulla of Vater
is still unknown.
Treatment options for periampullary tumors are surgi-
cal resection, operative or nonoperative palliation, and
neoadjuvant or adjuvant therapies regardless of histo-
pathology of tumor. Surgical resection which was also
the choice of treatment in our case is the major treat-
ment method for periampullary tumors. In another case
of primary squamous cell carcinoma of the ampulla of
Vater, the patient underwent curative resection without
any further treatment and overall survival was 5 months
after surgery was reported [5].
With limited experience of primary squamous cell
carcinoma in the ampulla of Vater, long-term sur-
vival rates are not well known. On the other hand,
pure squamous cell carcinomas of the biliary tract
are associated with decreased survival rates com-
pared to adenocarcinomas and adenosquamous car-
cinomas [18, 19]. Therefore, we suggest that primary
squamous cell carcinomas of the ampulla of Vater
should be considered as more aggressive than adeno-
carcinomas, and adjuvant chemotherapy should be
recommended as another treatment option.
Different adjuvant chemotherapy regimens have been
investigated for metastatic and advanced ampullary
adenocarcinomas in recent years. Shoji et al. reported a
retrospective study comparing 5-fluorouracil-based reg-
imens with gemcitabine-based regimens for median
progression-free survival and median overall survival
time in patients with advanced ampullary adenocarcin-
omas [20]. Median overall survival time was found to
be longer with gemcitabine-based regimens. A phase II
study evaluated the efficacy of a combination regimen
of capecitabine with oxaliplatin in advanced ampullary
and small bowel adenocarcinomas [21]. The response
rate for this regimen was lower in the ampullary adeno-
carcinomas compared to small bowel adenocarcinomas.
This difference was suggested to be related with the
heterogenous epithelium of origin and the molecular
heterogeneity for ampullary tumors. In many centers,
the general approach to periampullary cancers has been
to use gemcitabine-based regimens for pancreatic and
biliary carcinomas and fluorouracil-based regimens for
Fig. 8 The presence of keratin pearls within the islets of atypical
squamous cells
Fig. 7 Tumor invasion to the common bile duct
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duodenal and ampullary carcinomas which is also the
choice of treatment in our center.
Conclusions
Primary squamous cell carcinoma of the ampulla of
Vater is a very rare histological type with an unclear
pathogenesis mainly due to a limited number of cases
reported. A better understanding of pathogenesis might
be helpful in optimizing the treatment for this specific
rare type of tumor.
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